Aditxt, Inc. and Copley Acquisition Corp mutually terminated their Business Combination Agreement on October 9, 2026, ending the proposed merger that would have taken Aditxt public via a special purpose acquisition company. The termination is effective immediately, with each party bearing its own expenses and mutual releases of claims. This development removes the near-term catalyst for a liquidity event through the SPAC transaction, leaving the biotechnology company to pursue alternative strategic options or financing independently.
